Black people still experience highest burden of air pollution-related deaths

Health benefits that have resulted from reductions in fine particulate air pollution aren’t distributed equally among populations in the U.S., a new Yale-led study finds.

Accord BioPharma’s HERCESSI gets FDA approval

HERCESSI is approved for treating HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric or gastroesophageal junction adenocarcinoma. Credit: Lightspring/Shutterstock. Accord BioPharma, the speciality division

September 19, 2024

BMB-101 by Bright Minds Biosciences for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 14, 2024

This Is a Better Time to Buy Cannabis Stocks

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

June 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.